Kenvue Inc. has officially changed its corporate structure to Kenvue LLC following its acquisition by Kimberly-Clark Corporation. This significant transition, completed on November 2, 2026, marks a strategic consolidation within the perfumes, cosmetics, and toilet preparations industry.
The merger, executed under the Agreement and Plan of Merger, involved Kenvue merging with a wholly owned subsidiary of Kimberly-Clark. As part of this transaction, Kenvue will now operate as a direct subsidiary of Kimberly-Clark, which aims to enhance operational efficiency and market competitiveness.
Background
Kenvue Inc., categorized under SIC 2844 for perfumes, cosmetics, and other toilet preparations, is a prominent player in the consumer goods sector. The company trades under the ticker KVUE on the New York Stock Exchange (NYSE). Recent filings include various forms, with the latest being the S-8 POS filed on November 2, 2026.
What the Filing Says
The SEC filing indicates that Kenvue has terminated all offerings of its securities pursuant to existing registration statements. The filing states, "the Company, as successor in interest to Kenvue, hereby removes from registration any and all securities of Kenvue registered but unsold under the Registration Statements as of the date hereof." This deregistration reflects the completion of the merger and the subsequent changes in corporate structure.
Impact
This transition may affect various stakeholders, including investors who previously held Kenvue securities. The termination of existing registration statements means that Kenvue LLC will no longer offer these securities, which could lead to shifts in investment strategies within the industry. Competitors in the perfumes and cosmetics market may also feel the impact as Kenvue LLC integrates into Kimberly-Clark's broader business operations.
What's Next
The filing does not say what happens next.
Read Next
Catalyst Acquisition Corp. Updates Beneficial Ownership Stakes
Hampton Financial Corp Raises Governance Concerns Over Icon Energy
HCA Healthcare Executive Reports Multiple Stock Transactions
LENZ Therapeutics updates beneficial ownership in SEC filing
LOR Inc. Acquires Over 1.4 Million Shares of Rollins Inc.
Brian Magnusson Reports New Stock Transactions at Lindsay Corp









